Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response

Published:2017-05 Issue:5 Volume:38 Page:372-382
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:

Author:

Han Junbin,Liu Hui,Liu Chunling,Jin Hongjun,Perlmutter Joel S.,Egan Terrance M.,Tu Zhude

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference37 articles.

1. Precision medicine in multiple sclerosis: future of PET imaging of inflammation and reactive astrocytes;Poutiainen;Front Mol Neurosci,2016

2. P2X7 receptor: an emerging target in central nervous system diseases;Sperlagh;Trends Pharmacol Sci,2014

3. The microglial ATP-gated ion channel P2X7 as a CNS drug target;Bhattacharya;Glia,2016

4. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore;Monif;J Neurosci,2009

5. Altered cytokine production in mice lacking P2X(7) receptors;Solle;J Biol Chem,2001

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders;Frontiers in Pharmacology;2024-07-30

2. Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists;Current Medicinal Chemistry;2024-04

3. Positron emission tomography imaging of the P2X7 receptor with a novel tracer, [¹⁸F]GSK1482160, in a transgenic mouse model of Alzheimer's disease and healthy non‐human primates;Brain‐X;2024-03

4. A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-02-13

5. Preclinical Evaluation of Novel PET Probes for Dementia;Seminars in Nuclear Medicine;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3